Market revenue in 2023 | USD 62.8 million |
Market revenue in 2030 | USD 89.8 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Large molecules |
Fastest growing segment | Small molecules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Large Molecules, Small molecules |
Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Large molecules was the largest segment with a revenue share of 67.04% in 2023. Horizon Databook has segmented the Mexico fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.
Mexican pharmaceutical companies are expanding their presence in contract manufacturing, thereby driving the market. For instance, PiSA Farmaceutica, one of the Mexico’s prominent pharmaceutical companies, is geared to expand its business in contract manufacturing, which is expected to aid in revenue generation in the country.
Furthermore, due to inclusion in government programs in Mexico, biosimilars are found to be less expensive than in Brazil. This factor is also expected to have positive impact on the development of finished formulations.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account